Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Abstract Mesenchymal stem cells (MSC) comprise a heterogeneous population of rapidly proliferating cells that can be isolated from adult (e.g., bone marrow, adipose tissue) as well as fetal (e.g., umbilical cord) tissues (termed bone marrow (BM)-, adipose tissue (AT)-, and umbilical cord (UC)-MSC, r...
Main Authors: | Ioannis Christodoulou, Maria Goulielmaki, Marina Devetzi, Mihalis Panagiotidis, Georgios Koliakos, Vassilis Zoumpourlis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-018-1078-8 |
Similar Items
-
Germline cells derived from mesenchymal stem cells, with the focus on Wharton's jelly
by: Hossein Yazdekhasti, et al.
Published: (2018-01-01) -
Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy
by: Agnieszka Owczarczyk-Saczonek, et al.
Published: (2017-10-01) -
Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials
by: Katarzyna Stefańska, et al.
Published: (2020-04-01) -
Evaluation of the effect of an intradermal injection of Wharton\'s jelly-derived mesenchymal stem cells in diabetic wound healing in animal model
by: Sona Zare, et al.
Published: (2021-02-01) -
Porcine Wharton’s jelly cells distribute throughout the body after intraperitoneal injection
by: Kreeson Packthongsuk, et al.
Published: (2018-02-01)